Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NCF1 | P14598 | 4/20 | 0.40 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | PTGES | O14684 | 4/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | S1PR4 | O95977 | 3/20 | 0.34 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.33 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.33 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7570410 | 0.75 | TDP1 (0.36) | MAPK14L3MBTL1KDM4EGAATDP1 | |
| SCHEMBL13564152 | 0.74 | NCF1 (0.41) | NCF1MAPK14L3MBTL1KDM4ESMN1; SMN2 | |
| SCHEMBL7588939 | 0.72 | GAA (0.51) | NCF1MAPK14L3MBTL1KDM4ESMN1; SMN2 | |
| SCHEMBL15485538 | 0.71 | NCF1 (0.39) | NCF1L3MBTL1KDM4ESMN1; SMN2TDP1 | |
| SCHEMBL6377587 | 0.69 | HTR7 (0.61) | NCF1MAPK14L3MBTL1KDM4ESMN1; SMN2 | |
| SCHEMBL911440 | 0.69 | HPGD (0.40) | SMN1; SMN2TDP1POLBS1PR4PDE3B | |
| SCHEMBL29581181 | 0.69 | HPGD (0.40) | SMN1; SMN2TDP1POLBS1PR4PDE3B | |
| SCHEMBL7713782 | 0.68 | NPC1 (0.40) | NCF1L3MBTL1KDM4ESMN1; SMN2GAA | |
| SCHEMBL14294218 | 0.68 | KDM4E (0.39) | NCF1L3MBTL1KDM4ESMN1; SMN2 | |
| SCHEMBL13518500 | 0.68 | MAPT (0.42) | NCF1L3MBTL1PTGESPDE3BPDE3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020115865-A1 | 2-methoxyimino-2- (pyridinyloxymethyl) phenyl acetamides with polyether derivatives on the pyridine ring | CANADA EMILY J (US) | 2002-08-22 | — | — | US | disclosed |
| US-6432990-B1 | FUNGICIDES | DOW AGROSCIENCES LLC | 2002-08-13 | — | — | US | disclosed |
| US-6369083-B1 | 2-methoxyimino-2 (pyrinyloxymethyl) phenyl acetamides with polyether derivatives on the pyridine ring | DOW AGROSCIENCES LLC | 2002-04-09 | — | — | US | disclosed |
| WO-2000015635-A1 | 2-METHOXYIMINO -2-(PYRIDINYLOXYMETHYL) PHENYL ACETAMIDES USEFUL AS FUNGICIDES | DOW AGROSCIENCES LLC (US) | 2000-03-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020115865-A1 | 2-methoxyimino-2- (pyridinyloxymethyl) phenyl acetamides with polyether derivatives on the pyridine ring | AADAC, MIDEAS, CNPY2 | NCF1 4617/4885MAPK14 1423/4885L3MBTL1 2276/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.